Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency

Abstract

This cohort provides the largest analysis for clinical and immunological features of MALT1 deficiency. HSCT should be offered as a curative therapeutic option for all patients at the early stage of life.